Dipendra Bhandari
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Dipendra Bhandari has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Annie Aniana
Laboratory of Chemical Physics, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, DHHS, Bethesda, MD 20892-0520, USA
2 shared publications - John M. Louis
Laboratory of Chemical Physics, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, DHHS, Bethesda, MD 20892-0520, USA
2 shared publications - Adepu Kiran Kumar
Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, USA
1 shared publication - Ahmad Mani-Varnosfaderani
Chemometrics and Cheminformatics Laboratory, Department of Analytical Chemistry, Tarbiat Modares University, Tehran, Iran
1 shared publication Andrey Kovalevsky
Neutron Scattering Division, Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA
1 shared publication- Andrey Kovalevsky
Neutron Scattering Division, Oak Ridge National Laboratory, Oak Ridge, TN 37831, USA
1 shared publication
Latest Publications
- Open Access
- 1 September 2026
- Published by Royal Society of Chemistry (RSC) in RSC Medicinal Chemistry
- Vol. 17 (9) , 4483-4501
Noncovalent SARS-CoV-2 main protease inhibitors targeting the catalytic dyad and primed substrate binding subsites
Novel noncovalent SARS-CoV-2 main protease inhibitors were designed, targeting catalytic dyad and primed binding subsites. Neutron diffraction revealed new conventional and nonconventional interactions, offering insights for future inhibitor design.
- 1 September 2026
- Published by Royal Society of Chemistry (RSC) in RSC Medicinal Chemistry
- Vol. 17 (9) , 4483-4501
Open AccessNoncovalent SARS-CoV-2 main protease inhibitors targeting the catalytic dyad and primed substrate binding subsites
Novel noncovalent SARS-CoV-2 main protease inhibitors were designed, targeting catalytic dyad and primed binding subsites. Neutron diffraction revealed new conventional and nonconventional interactions, offering insights for future inhibitor design.
- Open Access
- 26 August 2026
- Published by Springer Nature in Metabolomics
- Vol. 22 (5) , 146
From known chemical space to unannotated metabolites: a cluster-guided retention-time driven framework for biologically informed annotation
- 26 August 2026
- Published by Springer Nature in Metabolomics
- Vol. 22 (5) , 146
Open AccessFrom known chemical space to unannotated metabolites: a cluster-guided retention-time driven framework for biologically informed annotation
- Open Access
- 21 March 2026
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 302 (5) , 111395
Cleavage at the nsp5–nsp6 site of SARS-CoV-2 main protease intermediate precursor is faster from a monomer than a dimer form
- 21 March 2026
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 302 (5) , 111395
Open AccessCleavage at the nsp5–nsp6 site of SARS-CoV-2 main protease intermediate precursor is faster from a monomer than a dimer form